Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Equity Ratio (2021 - 2026)

Centessa Pharmaceuticals has reported Equity Ratio over the past 5 years, most recently at 0.77 for Q4 2025.

  • Quarterly Equity Ratio rose 10.08% to 0.77 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.77 through Dec 2025, up 10.08% year-over-year, with the annual reading at 0.77 for FY2025, 10.08% up from the prior year.
  • Equity Ratio was 0.77 for Q4 2025 at Centessa Pharmaceuticals, up from 0.67 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.82 in Q1 2022 and troughed at 0.66 in Q1 2024.
  • The 5-year median for Equity Ratio is 0.73 (2023), against an average of 0.73.
  • Year-over-year, Equity Ratio rose 19.1% in 2024 and then fell 17.83% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.78 in 2021, then dropped by 3.08% to 0.76 in 2022, then dropped by 13.33% to 0.66 in 2023, then rose by 6.16% to 0.7 in 2024, then rose by 10.08% to 0.77 in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Equity Ratio are 0.77 (Q4 2025), 0.67 (Q3 2025), and 0.7 (Q2 2025).